Bakuchiol 90%, 98% & 99%: Why Purified Bakuchiol Is Not the Same as Bakuchi Oil or Psoralea Extract

Disclosure: We may earn a commission if you purchase through links on this page, at no additional cost to you.
Quick Answer
Bakuchiol sourcing becomes confusing as soon as a buyer searches beyond the ingredient name. Current commercial pages use overlapping labels such as Bakuchiol 98%, Bakuchiol 99%, Bakuchiol oil, Psoralea corylifolia extract, babchi oil and bakuchi oil. Some of those offers may contain highly purified Bakuchiol. Others may describe a broader botanical oil or extract. Those materials are not automatically interchangeable.
Bakuchiol itself is a defined molecule. PubChem identifies (+)-Bakuchiol as C18H24O, molecular weight 256.4 g/mol, CAS 10309-37-2.[1] A Psoralea corylifolia seed oil or whole extract is a multicomponent botanical material that can contain Bakuchiol together with other constituents. That distinction matters because Psoralea corylifolia also contains furocoumarins, including psoralen-related compounds with established photosensitizing or phototoxic potential.[2][3]
For a technical buyer, the correct question is therefore not simply Is this 98% or 99%? It is: what exact material is being sold, how is Bakuchiol quantified, what remains in the non-Bakuchiol fraction, and are relevant psoralen-type impurities controlled for the intended cosmetic use?
The sourcing sequence should be:
identity → material type → assay method and basis → impurity profile → batch COA → physical form → formulation fit → supplier traceability → commercial terms.
Start with Identity: Purified Bakuchiol Is a Defined Molecule
Bakuchiol is not simply a marketing name for any Psoralea-derived oil. The defined compound has CAS 10309-37-2 and a specific molecular structure.[1] A buyer evaluating a purified Bakuchiol offer should expect the product name, CAS, INCI identity where supplied, specification, quotation, label and batch documentation to point to the same material. If a marketplace listing calls a product Bakuchiol 99% but the technical document only identifies Psoralea corylifolia extract without a clear Bakuchiol assay, the identity is not sufficiently resolved for a high-purity comparison.
Likewise, Bakuchiol oil can be ambiguous. A supplier may use the phrase to describe purified Bakuchiol because the material is an oily liquid, or it may refer to a broader botanical oil. Do not infer composition from the word oil. Require the exact chemical identity and quantitative specification.
Why Bakuchi or Babchi Oil Is Not a Synonym for Purified Bakuchiol
Bakuchi, babchi and Psoralea corylifolia are botanical-source terms. A seed oil or plant extract can contain multiple native constituents. Purified Bakuchiol is one isolated constituent from that broader chemical context. A 2023 Journal of Cosmetic Dermatology article specifically warned that unpurified Psoralea preparations can contain phototoxic psoralens and furocoumarins, and argued that facial-care products should use purified Bakuchiol rather than poorly purified plant material.[3]
A broader toxicology review of Psoralea corylifolia also documents the plant's photosensitizing activity and discusses psoralen-related phototoxicity.[2] This does not mean every babchi-derived ingredient is unsuitable for cosmetics. It means the buyer must qualify the exact material for the intended product. A botanical oil designed to preserve a wider phytochemical profile should be evaluated as that botanical material. A high-purity Bakuchiol active should be evaluated as purified Bakuchiol. The two should not borrow each other's specifications.
What 90%, 98% and 99% Can Mean in the Current Market
Current public commercial pages checked in September 2026 show Bakuchiol offers described around 90%, 98% and 99% purity or assay. That range does not establish an official global grade ladder. One scientific analytical paper notes that cosmetic production may use Bakuchiol carrier oil or approximately 90% pure Bakuchiol obtained through extraction and purification.[4] Current commercial supply commonly advertises 98% or 99% HPLC material. The important sourcing question is not whether 99 is numerically higher than 98.
First determine what the percentage represents. A supplier may mean quantitative Bakuchiol assay against a reference standard. Another may report HPLC area-normalized chromatographic purity. A third may use the percentage as a marketing shorthand without showing enough method detail. Those numbers should not be compared until the analytical basis is aligned. A nominal 99% claim with weak identity and impurity documentation can be less useful than a 98% offer with a clear method, lot-specific result and controlled psoralen specification.
HPLC Assay and Chromatographic Purity Can Answer Different Questions
HPLC is widely used to analyze Bakuchiol, but HPLC 99% is incomplete information. Ask whether the value is a quantitative assay against an external standard or an area-percentage purity result from the chromatogram. A quantitative assay is intended to estimate the amount of Bakuchiol in the sample according to the specified method and calibration. Area normalization describes the relative chromatographic signal assigned to the main peak under that method. Those values may be close, but they are not automatically identical.
The 2023 Scientific Reports paper developed a chromatographic method for determining Bakuchiol in cosmetic products and emphasizes the importance of analytical separation and quantification rather than relying only on a product label.[4] For sourcing, request the current specification, method description or reference, and the batch COA. If the supplier reports both assay and chromatographic purity, preserve both fields rather than collapsing them into one number.
The Non-Bakuchiol Fraction Matters
A 98% or 99% material is not 100% Bakuchiol. The remaining fraction can include water or volatile matter, process-related residuals, structurally related compounds, other botanical constituents or unidentified chromatographic peaks depending on the production and purification route. This is why impurity control matters more than the headline difference between 98 and 99. For Psoralea-derived material, psoralen and isopsoralen are particularly important because they belong to a photoreactive chemical family associated with photosensitization risk.[2][3]
Current commercial specifications can explicitly control psoralen/isopsoralen at low ppm levels, showing that suppliers recognize this as a differentiating quality field. Do not copy one supplier's limit into a universal standard unless a relevant regulatory or customer specification requires it. Instead, ask every candidate supplier whether psoralen and related furocoumarins are part of the release specification, which method is used, and what the actual batch result is.
Psoralen Control Is Not the Same as Bakuchiol Assay
A supplier can report 99% Bakuchiol and still need a separate psoralen test. The Bakuchiol assay answers how much target compound is present. A psoralen specification answers whether a particular unwanted constituent is controlled below an acceptance limit. One test cannot be silently substituted for the other. If the intended market, brand standard or safety assessment treats furocoumarin exposure as material, ask for the specific analytical result rather than accepting high purity as indirect proof.
This is especially important when a supplier uses plant-source language heavily but provides limited information on purification.
Physical Form Can Help Reveal Whether Two Offers Are Actually Comparable
Purified Bakuchiol is commonly supplied as an oily or viscous liquid rather than a dry plant-extract powder. Current high-purity supplier pages describe pale-yellow to brownish oily liquids and oil-soluble behavior. Research-chemical suppliers also sell high-purity Bakuchiol as a defined compound.
A marketplace offer described as Bakuchiol powder should therefore trigger a clarification step: is the powder purified Bakuchiol on a carrier, a spray-dried extract, a different concentration, or simply a poorly labeled product?
Do not reject powders automatically. Determine the composition. The same rule applies to color. Darker color does not by itself prove low purity, and a pale color does not prove adequate psoralen control. Physical appearance is an incoming-inspection field, not a substitute for chemical analysis.
Do Not Transfer Finished-Product Clinical Evidence to a Botanical Oil
Bakuchiol has published human topical evidence. In a randomized, double-blind 12-week trial, 44 participants used either a 0.5% Bakuchiol cream twice daily or a 0.5% retinol cream once daily. Both groups improved measured photoageing outcomes, while the retinol group reported more scaling and stinging.[5] That study supports the use of Bakuchiol as the tested active in the tested formulation. It does not prove that bakuchi oil, babchi oil or an unstandardized Psoralea extract delivers the same exposure or clinical effect.
A shared botanical source does not make materials clinically interchangeable. For procurement, clinical evidence should be mapped back to the identity and concentration of the active actually studied.
A Practical Buyer Comparison Matrix
Normalize the identity and analytical fields before comparing price or supplier marketing.
| Review field | Purified Bakuchiol | Bakuchi/Babchi oil or extract | Buyer action |
|---|---|---|---|
| Identity | Defined Bakuchiol / CAS 10309-37-2 | Multicomponent botanical material | Do not treat as synonyms |
| Bakuchiol content | High assay, often 90-99% depending on grade | May be low, variable or differently standardized | Confirm method and basis |
| Psoralen risk | Should be controlled by purification/specification where relevant | May contain native furocoumarins depending on material | Request specific impurity data |
| Physical form | Often oily/viscous liquid | Oil, extract, powder or carrier system | Confirm full composition |
| Clinical transfer | Can map to studies only when identity/formulation is relevant | Cannot inherit purified-Bakuchiol evidence | Keep evidence identity-specific |
| Price comparison | Compare after assay/impurity normalization | Price reflects broader matrix, not same active basis | Do not compare $/kg directly |
What Should Be on the Bakuchiol RFQ?
- Exact product name, grade, CAS and INCI.
- Botanical source and purification route where relevant.
- Material type: purified Bakuchiol, seed oil, plant extract, carrier dilution or other.
- Bakuchiol assay specification and test method.
- Whether the reported percentage is quantitative assay or chromatographic purity.
- Actual lot Bakuchiol result.
- Psoralen and isopsoralen/furocoumarin controls, method and lot result where applicable.
- Residual solvents and other route-relevant impurities.
- Pesticides, heavy metals and microbiology where relevant to the grade.
- Physical form, color range, odor and solubility/compatibility description.
- Packaging, storage and retest/expiry information.
- Representative COA plus lot-specific COA before shipment.
- HPLC chromatogram or additional identity data when needed for qualification.
- MOQ, sample size, quantity tiers, lead time and Incoterm.
- Change-control policy for source, purification process, site or specification.
Hard-Reject Conditions Before Commercial Comparison
Some Bakuchiol listings should not proceed to price or supplier scoring at all. A hard reject is appropriate when the seller cannot establish the exact material identity, when CAS 10309-37-2 conflicts with another chemical identity, when the quoted 98% or 99% cannot be connected to any defined analytical method, or when the product is simultaneously described as purified Bakuchiol and a generic Psoralea extract without clarifying the composition.
Another hard stop is an unresolved batch-document conflict. If the quotation, specification and COA describe different grades, physical forms or source materials, the buyer should not average the information and proceed. For a facial-care project, an offer that claims purified Bakuchiol but refuses to address psoralen/furocoumarin control deserves the same treatment when those impurities are part of the project's safety specification.
These gates are intentionally stricter than normal marketplace screening. They prevent a cheap or high-commission listing from entering the final comparison before the product itself has been defined.
Incoming QC: Verify the First Commercial Lot, Not Only the Sample
The first evaluation sample can establish formulation fit, but it should not become permanent evidence for every future shipment. When the first commercial lot arrives, reconcile the supplier name, product code, CAS, lot number, manufacture or test date, assay specification and actual result against the approved documents. Confirm that the material still matches the expected physical form and color range. If the project depends on a specific psoralen or isopsoralen limit, verify that the lot-specific COA reports the required field or obtain the associated analytical result.
For higher-risk or new suppliers, independent identity or assay testing can be used as a qualification tool. The scope should follow the real risk: a buyer may need Bakuchiol identity and quantitative assay, or may additionally need a furocoumarin check when that field is critical to the intended product. The purpose is not to retest every parameter forever. It is to establish confidence that the commercial lot matches the material qualified during sampling and that the supplier's documentation remains traceable.
If the first production lot differs materially from the sample in assay basis, impurity specification, source, physical form or document architecture, reopen qualification before formula scale-up.
Current Sourcing Status
Ingredexa currently uses one Bakuchiol Alibaba sourcing link lead in this article as a directionally verified sourcing option. Landing verification on the sourcing link confirms that the link opens to its intended Alibaba product. It does not replace current specification, batch COA, Bakuchiol identity, HPLC assay basis, psoralen/isopsoralen controls, manufacturer traceability, MOQ or commercial-term review. Affiliate tracking in Alibaba Reports remains a separate verification state from landing verification and should be checked when order/click data become available.
Buyer Decision
Bakuchiol sourcing should begin with identity, not the percentage printed in a listing title. Purified Bakuchiol is a defined molecule. Bakuchi oil, babchi oil and Psoralea corylifolia extract are broader botanical materials and should not be treated as synonyms. Once identity is confirmed, interpret 90%, 98% or 99% only after the HPLC method and calculation basis are clear. Then look at the non-Bakuchiol fraction, especially psoralen/isopsoralen or other relevant furocoumarins when the material is derived from Psoralea corylifolia.
A one-percentage-point purity difference is rarely the most important sourcing variable if one supplier provides clear impurity control and lot traceability while another provides only a headline number. The defensible purchasing sequence is therefore: exact material → assay definition → impurity control → batch evidence → formulation fit → supplier continuity → commercial comparison. That framework gives the new Bakuchiol cluster a clean starting point and prevents later articles on COA, price, processing or supplier qualification from inheriting an unresolved identity problem.
References
- PubChem. (+)-Bakuchiol, CID 5468522. National Library of Medicine. Accessed September 24, 2026.
- Zhang X, Zhao W, Wang Y, et al. Psoralea corylifolia L.: a comprehensive review of its botany, traditional uses, phytochemistry, pharmacology, toxicology, quality control and pharmacokinetics. Chinese Medicine. 2023;18:4.
- Afzal M, et al. Finding the right Bakuchiol: Choose wisely. Journal of Cosmetic Dermatology. 2023.
- Development of a new chromatographic method for the determination of bakuchiol in cosmetic products. Scientific Reports. 2023;13:13791.
- Dhaliwal S, Rybak I, Ellis SR, et al. Prospective, randomized, double-blind assessment of topical bakuchiol and retinol for facial photoageing. British Journal of Dermatology. 2019;180(2):289-296.
Related content
Continue exploring related ingredient research and sourcing guides.

Does Bakuchiol Degrade in Cosmetics? How to Test Light, Heat and Batch Stability
A buyer-side guide to interpreting bakuchiol stability data, testing the active in your own formula and packaging, and telling a raw-material problem from a formula or process problem.

Why Bakuchiol Does Not Simply Dissolve in Water-Based Serums
A formulation decision guide to Bakuchiol solubility: separating free solubility from dispersion, choosing between oil-phase, premix and nanocarrier routes, and running compatibility and assay checks that actually answer the question.

Bakuchiol Solubility & Processing Temperature: Why Oil-Soluble Is Not a Complete Formulation Instruction
Learn how Bakuchiol's lipophilicity affects oil-phase incorporation, aqueous systems, processing temperature, light exposure and finished-formula validation.

Bakuchiol Usage Level: What 0.5% Clinical Evidence Shows vs 0.1-2% Formulation Ranges
Compare Bakuchiol 0.5% clinical evidence with 0.1-2% formulation and regulatory ranges. Learn how purity, active-equivalent dosage and finished-formula validation change the buyer decision.